Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514397, 514254, 514354, 514356, 514383, 544353, 544354, 544355, 544356, A01N 4358, A01N 4340, A01N 4382, C07D24136
(1H-azol-1-ylmethyl)substituted quinoxaline derivatives, compositions containing the same, and methods of treating mammals suffering from disorders which are characterized by an increased proliferation and/or abnormal differentiation of epithelial tissues.
Chytil, Pharmacological Reviews, 36, pp. 93-100 (1984).
Elias, et al, Arch. Dermatol., 117, pp. 160-180 (1981).
Lotan, Biochinica et Biophysica, ACTA, 605, pp. 33 et seq. (1980).
Thomas et al, J. Am. Acad. Dermatol, 4, pp. 505 et seq. (1981).
Freyne Eddy J. E.
Raeymaekers Alfons H. M.
Sanz Gerard C.
Venet Marc G.
Criares T. J.
Janssen Pharmaceutica N.V.
Metz Charles J.
Waddell Frederick E.
(1H-azol-1-ylmethyl) substituted quinoxaline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with (1H-azol-1-ylmethyl) substituted quinoxaline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (1H-azol-1-ylmethyl) substituted quinoxaline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1968700